Skip to content

MiMedx Group MDXG Change in AP

Change in AP at other companies

IAR
Integra LifeSciencesIART
-$19.19M-6.6%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
-$2M+19.8%
Artivion logo
ArtivionAORT
-$8.7M+45.8%
Solventum logo
SolventumSOLV
$23M+156%
Vericel logo
VericelVCEL
$2.59M+570%
Enovis logo
EnovisENOV
$26.89M+542%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's change in AP?
MiMedx Group (MDXG) reported change in AP of $1.94M in Q1 2026.
How has MiMedx Group's change in AP changed year-over-year?
MiMedx Group's change in AP increased by 32.6% year-over-year, from $1.46M to $1.94M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.